PatternsRadar
Sign in

POLYMEDPoly Medicure Limited

NSE
Full chart
1,633.80INR+14.20 (+0.88%)Close · 6 Oct 2026
7 Aug 2026Last results
HealthcareSector
Healthcare Equipment & SuppliesIndustry
₹16,560 CrMarket cap
52.9P/E (TTM)
62.0%Delivery

Filings & corporate actions

62 results filed
CSV
Next results · Q2 FY27
Expected 28 Oct 2026 – 8 Nov 2026
Estimate: filed 28–39 days after quarter end, last 5 times
Dividend
₹3.50 per share · last 28 Aug 2026
2026
  • 28 AugdividendDividend · ₹3.50 per share+1.2%
  • 7 AugresultsResults · Q1 FY27 · consolidated and standalone+4.6%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026-1.5%NSE
  • 25 MayresultsResults · Q4 FY26 · consolidated and standalone-6.9%NSE
  • 21 AprshareholdingShareholding · 31 Mar 2026+1.7%NSE
  • 5 FebresultsResults · Q3 FY26 · consolidated and standalone-7.5%NSE
  • 20 JanshareholdingShareholding · 31 Dec 2025-1.4%NSE

Reaction to results · all yearsrose on day 0 in 23 of 60 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY277 Aug 2026+4.6%+2.3%+0.4%9.5×
Q4 FY2625 May 2026-6.9%-13.4%+6.7%4.3×
Q3 FY265 Feb 2026-7.5%-14.2%-12.2%2.7×
Q2 FY268 Nov 2025-1.7%+2.6%-1.9%1.0×
Q1 FY268 Aug 2025+2.4%-1.4%+1.0%3.6×
Q4 FY257 May 2025+1.9%-15.4%-19.6%3.9×
Q3 FY253 Feb 2025+5.8%-1.3%-3.0%7.0×
Q2 FY2528 Oct 2024-2.1%+7.3%+4.3%1.0×
Q1 FY2522 Jul 2024-0.5%-3.9%+6.8%0.5×
Q4 FY2417 May 2024+1.1%+10.1%+19.8%0.1×
Q3 FY2431 Jan 2024+1.6%+7.4%+7.3%1.7×
Q2 FY244 Nov 2023-6.2%-1.0%+11.9%2.8×
Q1 FY247 Aug 2023-4.4%-4.0%-5.9%0.7×
Q4 FY2310 May 20230.0%+1.8%+0.4%0.7×
Q3 FY2328 Jan 2023-1.8%-4.5%+8.6%1.3×
Q2 FY235 Nov 2022+1.0%+2.2%+0.1%2.0×
Q1 FY234 Aug 2022-1.4%-0.5%+16.6%0.6×
Q4 FY2224 May 2022-0.3%+8.7%+0.6%0.5×
Q3 FY2231 Jan 2022-0.9%-8.8%-12.2%3.1×
Q2 FY221 Nov 2021-0.6%-1.0%+14.4%0.3×
Q1 FY2229 Jul 2021-1.3%-3.0%-5.5%0.4×
Q4 FY2125 May 2021-0.5%-3.9%-8.5%3.1×
Q3 FY2127 Jan 2021-1.3%+1.0%+38.7%0.3×
Q2 FY2128 Oct 2020-0.4%+0.1%+1.0%0.4×
Q1 FY2130 Jul 2020-2.0%+2.3%+7.1%1.1×
Q4 FY205 Jun 2020-1.6%+1.8%+6.0%0.6×
Q3 FY201 Feb 2020+3.1%+16.2%+7.8%1.2×
Q2 FY2011 Nov 2019+7.8%+7.1%+2.2%9.7×
Q4 FY194 Sept 2019+3.2%+13.1%+5.8%1.0×
Q1 FY2013 Aug 2019+3.5%+2.5%+24.6%1.0×
Q3 FY1928 Jan 2019-0.6%-0.3%-5.1%1.6×
Q2 FY1912 Nov 2018-1.2%-2.3%+5.0%0.2×
Q1 FY1910 Aug 2018-0.2%+10.9%-2.8%0.3×
Q4 FY1818 Jun 2018-1.7%-11.4%-4.0%0.7×
Q3 FY1821 Feb 2018-0.3%+3.6%+3.9%0.3×
Q2 FY188 Nov 2017+1.8%-2.2%-3.7%0.8×
Q1 FY1823 Aug 2017+1.4%-1.8%+6.1%0.3×
Q4 FY1717 Jun 2017-0.9%+5.9%+2.0%1.2×
Q3 FY178 Feb 2017+1.7%-2.3%+1.8%0.7×
Q2 FY1716 Nov 2016-0.9%-0.2%+4.8%0.4×
Q1 FY1713 Aug 2016+1.7%+0.2%-2.5%2.1×
Q4 FY1625 May 2016+2.2%-1.6%+9.8%4.2×
Q3 FY169 Feb 2016-4.3%-6.9%+2.9%0.8×
Q2 FY162 Nov 2015-0.4%-3.4%-4.6%0.3×
Q1 FY164 Aug 2015+3.4%+6.8%-8.9%1.8×
Q4 FY158 May 2015+2.6%-0.7%-4.7%0.5×
Q3 FY157 Feb 2015+2.6%+0.1%+2.1%0.6×
Q2 FY1510 Nov 2014+2.0%+3.9%+5.2%1.1×
Q1 FY157 Aug 2014+0.1%+0.8%+66.8%1.5×
Q4 FY1421 May 2014-0.4%+1.2%+2.6%1.0×
Q3 FY1429 Jan 2014-0.8%+11.3%+23.1%0.8×
Q2 FY146 Nov 2013+1.1%-0.4%-2.4%0.9×
Q1 FY145 Aug 2013-0.2%-0.3%-6.7%1.1×
Q4 FY1327 May 2013+0.1%+2.6%-1.4%1.0×
Q3 FY1311 Feb 2013-0.3%-1.3%-5.6%0.2×
Q2 FY1329 Oct 20120.0%-0.6%+22.2%0.4×
Q1 FY1331 Jul 2012-4.5%+1.3%+8.1%1.2×
Q4 FY1229 May 2012-0.5%+1.1%+11.0%0.2×
Q3 FY1231 Jan 2012-4.5%+3.7%+1.9%2.2×
Q2 FY126 Dec 2011————
Average-0.1%+0.5%+4.2%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+30.3%
Profit YoY-8.4%
Interest cost YoY—
Revenue QoQ-1.7%
Profit QoQ+31.1%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

CSV
Open1,613.00
Day range1,611.20 – 1,639.90
52-week range1,182.00 – 2,094.30
From 52w high-22.0%
RSI (14)39.9
ATR (14)51.50
Volume94.1K
Avg volume (20D)1.08L
Rel volume0.87×
Volatility (1Y)42.5%
Turnover₹15.4Cr
SMA 50 / 2001,722.55 / 1,570.72

Delivery percentage

Latest · 6 Oct 202662.0%
20-day avg46.4%
1-year avg46.6%
Percentile (own history)84th
Range6.7–97.8%
Sessions1,731

Over the last 20 sessions POLYMED settled 46.4% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 46.6%. The latest session ranks higher than 84% of the 1,731 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryMedical Equipment & Supplies
PeersMOLBIOTARSONSFISCHERLAXMIDENTLFABTECHGKB

Performance returns

CSV
1D1W1M3M6M1Y
Price+0.88%-0.18%-7.63%-2.15%+22.46%-16.62%

Valuation

CSV
Market cap₹16,560 Cr
P/E (TTM)52.9
EPS (TTM)30.87
Shares outstanding10.14Cr
Listed7 Dec 2011

Ownership

CSV
Promoter62.42%
Promoter Δ QoQ0.00 pp
Public37.58%
FII5.57%
DII16.08%
Pledged0.00%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)443.9493.7534.5525.4
YoY chg——+21.3%+30.3%
Net profit (₹ Cr)91.870.865.085.3
YoY chg——-29.2%-8.4%
Net margin20.7%14.3%12.2%16.2%
EPS9.066.996.538.48

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 62.42% · public 37.58%
30 Sept 2021: promoter 44.77%31 Dec 2021: promoter 44.76%31 Mar 2022: promoter 44.66%30 Jun 2022: promoter 53.34%30 Sept 2022: promoter 53.33%31 Dec 2022: promoter 53.33%31 Mar 2023: promoter 53.31%30 Jun 2023: promoter 53.31%30 Sept 2023: promoter 53.16%31 Dec 2023: promoter 53.16%31 Mar 2024: promoter 53.15%30 Jun 2024: promoter 66.03%22 Aug 2024: promoter 62.56%30 Sept 2024: promoter 62.56%31 Dec 2024: promoter 62.44%31 Mar 2025: promoter 62.44%30 Jun 2025: promoter 62.44%30 Sept 2025: promoter 62.42%31 Dec 2025: promoter 62.42%31 Mar 2026: promoter 62.42%30 Jun 2026: promoter 62.42%
2021-092026-06
  • Promoter
  • Public and others
Promoter
62.42%
Public
37.58%
Promoter change
0.00 pp
Filed
21 Jul 2026
FII
5.57%
DII
16.08%
Promoter pledged
0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations337.3339.6378.1384.8420.0424.2440.8403.2443.9493.7534.5525.4
Other income14.116.615.016.926.121.824.341.733.926.317.833.4
Total income351.4356.2393.0401.7446.1446.0465.1444.9477.8519.9552.3558.8
Total expenses271.3269.1300.8303.7328.9334.5344.6323.3357.1417.2468.8443.0
└ Finance costs2.23.53.13.23.33.32.23.03.06.06.46.5
└ Depreciation16.016.216.219.620.921.521.023.324.928.838.236.3
Profit before tax80.187.192.298.0117.2111.5120.6121.6120.795.983.5115.8
Tax expense18.822.824.124.430.528.031.029.929.926.820.232.0
Net profit62.265.068.474.087.585.291.893.191.870.865.085.3
EPS6.486.787.127.719.018.488.929.199.067.006.548.49
Net margin18.44%19.14%18.08%19.24%20.82%20.09%20.83%23.09%20.68%14.34%12.17%16.23%
PBT margin23.75%25.65%24.39%25.48%27.91%26.29%27.35%30.16%27.20%19.43%15.62%22.03%
Tax rate23.41%26.18%26.13%24.91%26.04%25.11%25.72%24.55%24.76%27.94%24.17%27.67%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 7 Aug 2026.

POLYMED at a glance

  • POLYMED closed at ₹1,633.8 on 6 Oct 2026, +0.88% on the day, -16.6% over one year, 22.0% below its 52-week high of ₹2,094.3.
  • Delivery was 62.0% of traded quantity on 6 Oct 2026, the 84th percentile of its own 1,731 sessions with a reading (20-session average 46.4%, 1-year average 46.6%).
  • Market capitalisation is ₹16,560 crore at a trailing P/E of 52.9 (trailing EPS ₹30.87).
  • Q1 FY27 results (consolidated, filed 7 Aug 2026): revenue ₹525 crore (+30.3% year on year), net profit ₹85 crore (-8.4%); the price moved +4.6% on the first session after.
  • Promoters held 62.42% at 30 Jun 2026, unchanged on the previous filing.
  • Q2 FY27 results are expected between 28 Oct 2026 and 8 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorHealthcare
Basic industryMedical Equipment & Supplies
ISININE205C01021
SeriesEQ
Listed7 Dec 2011
History from7 Dec 2011
Sessions3,670
Turnover rank#817

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Healthcare Equipment & Supplies

CSV

All Healthcare Equipment & Supplies stocks on the NSEAll Healthcare stocks on the NSE